World News: 14:00 GMT Monday 16th April 2018. [Biothera Pharmaceuticals, Inc. via Globe Newswire via SPi World News]
EAGAN Minn April 16 2018 GLOBE NEWSWIRE -- Biothera Pharmaceuticals Inc today announced the presentation of new translational data from ongoing phase 2 clinical trials combining Biotheras Imprime PGG with KEYTRUDA pembrolizumab an an ti-PD-1...
Globe Newswire: 14:00 GMT Monday 16th April 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.